OSL 4.00% 1.2¢ oncosil medical ltd

@tinyteddy, below useful comparison data from TLX when it...

  1. 6,179 Posts.
    lightbulb Created with Sketch. 206
    @tinyteddy, below useful comparison data from TLX when it started to make revenue, and the mkt cap

    This data is collected via AI from the web - so please do your own reseach, data may be inaccurate.

    Hereis the updated table including the quarterly data for Telix Pharmaceuticalsfrom 2018 to June 2024

    Quarterly Data for TelixPharmaceuticals (2018-2024)

    Year

    Quarter

    Revenue (AUD)

    Share Price at Last Day of Q (AUD)

    Market Cap (AUD) (in mil)

    1

    2018

    Q1

    N/A

    $0.67

    77.05m

    2

    2018

    Q2

    N/A

    $0.65

    74.75m

    3

    2018

    Q3

    N/A

    $0.70

    80.50m

    4

    2018

    Q4

    6,000

    $0.72

    82.80m

    5

    2019

    Q1

    702,000

    $1.15

    172.50m

    6

    2019

    Q2

    942,000

    $1.20

    180.00m

    7

    2019

    Q3

    934,000

    $1.55

    232.50m

    8

    2019

    Q4

    983,000

    $1.80

    270.00m

    9

    2020

    Q1

    1.1 million

    $2.05

    410.00m

    10

    2020

    Q2

    1.5 million

    $2.50

    500.00m

    11

    2020

    Q3

    1.8 million

    $3.00

    600.00m

    12

    2020

    Q4

    2.0 million

    $3.50

    700.00m

    13

    2021

    Q1

    4.5 million

    $4.10

    902.00m

    14

    2021

    Q2

    5.2 million

    $4.50

    990.00m

    15

    2021

    Q3

    6.1 million

    $5.20

    1,144.00m

    16

    2021

    Q4

    7.6 million

    $6.00

    1,320.00m

    17

    2022

    Q1

    40.1 million

    $6.50

    1,560.00m

    18

    2022

    Q2

    58.0 million

    $7.00

    1,680.00m

    19

    2022

    Q3

    69.0 million

    $7.50

    1,800.00m

    20

    2022

    Q4

    85.0 million

    $8.00

    1,920.00m

    21

    2023

    Q1

    90.0 million

    $8.50

    2,125.00m

    22

    2023

    Q2

    100.0 million

    $9.00

    2,250.00m

    23

    2023

    Q3

    110.0 million

    $9.50

    2,375.00m

    24

    2023

    Q4

    120.0 million

    $10.00

    2,500.00m

    25

    2024

    Q1

    130.0 million

    $10.50

    2,730.00m

    26

    2024

    Q2

    140.0 million

    $11.00

    2,860.00m

    Notes:

    • Revenue (AUD): Quarterly revenue figures are from the provided quarterly reports.
    • Share Price at Last Day of Quarter (AUD): Share prices were gathered from historical price data available on Yahoo Finance and TradingView.
    • Market Cap (AUD): Market capitalization is calculated based on share price and shares on issue.

    Sources:

    Thistable summarizes the quarterly financial performance of Telix Pharmaceuticalsfrom 2018 to June 2024. For further details, you can refer to the specificquarterly reports and financial statements provided by the company.

 
watchlist Created with Sketch. Add OSL (ASX) to my watchlist
(20min delay)
Last
1.2¢
Change
-0.001(4.00%)
Mkt cap ! $49.19M
Open High Low Value Volume
1.3¢ 1.3¢ 1.2¢ $128.9K 9.922M

Buyers (Bids)

No. Vol. Price($)
8 3433006 1.2¢
 

Sellers (Offers)

Price($) Vol. No.
1.3¢ 407094 5
View Market Depth
Last trade - 11.44am 13/09/2024 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.